Gujarat Themis Biosyn logo

Gujarat Themis Biosyn financials and balance sheet

NSE: GUJTHEMBSE: 506879Pharmaceuticals & BiotechnologySmall Cap

Last close ₹324.00down ₹29.40 (8.32%)BSE ₹327.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹353.40.

52-week range of traded prices to 23 Oct 2026
₹225.05Low, 30 Mar 2026₹479.00High, 27 Oct 2025
Market cap
₹4,217 Cr886th largest listed
P/E
86.6
P/B
Shares changed
Dividend yield
0.21%
ROE
18.2%
ROCE
15.1%
Debt to equity
0.56
Volume, NSE
9,32,72750.2% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Gujarat Themis Biosyn annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹170 Cr, year to Mar 2024

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.8% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue166
  2. Materials and goods−21
  3. Employee costs−17
  4. Other expenses−52
  5. Operating profit76
  6. Depreciation−13
  7. Other income+2.4
  8. One-off items0.0
  9. Finance costs−2.9
  10. Profit before tax62
  11. Tax−15
  12. Net profit47

What the company owns

  • Plant, investments and other assets₹421 Cr
  • Receivables₹61 Cr
  • Inventory₹15 Cr
  • Cash and bank₹6 Cr

What pays for it: net worth and liabilities

  • Net worth₹288 Cr
  • Borrowings₹160 Cr
  • Owed to suppliers₹37 Cr
  • Other liabilities₹19 Cr

Profit and loss

Standalone, ₹ crore, years to March.Gujarat Themis Biosyn quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 4 JunMar 2020Filed 19 MayMar 2021Filed 5 MayMar 2022Filed 24 MayMar 2023Filed 18 MayMar 2024Filed 16 MayMar 2025Filed 12 JunMar 2026Filed 20 Jun
Revenue from operations3639418591115149170151166
30333453505775918290
Materials and goods bought12111151726372521
Employee costs––56778101317
Other expenses––2736283341444552
Operating profit before depreciation66732405874796976
Operating margin16.8%16.1%17.9%37.4%44.5%50.5%49.8%46.4%45.7%45.5%
Materials, % of revenue––3.2%13.3%17.0%14.5%17.8%21.6%16.2%12.9%
Employee costs, % of revenue––12.7%7.6%7.9%6.2%5.2%6.0%8.4%10.0%
Other expenses, % of revenue––66.3%41.7%30.6%28.8%27.2%26.0%29.7%31.6%
Depreciation and amortisation11112234513
Operating profit after depreciation55630395672756363
Other income0022346422
Finance costs0001110003
One-off items––00000000
Profit before tax55831415977796662
0128111519201715
Net profit44624304458594947
Other comprehensive income––00000000
Total comprehensive income––624304458594947
Net margin11.9%10.0%15.6%27.8%33.3%38.0%38.9%34.8%32.3%28.2%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 4 JunMar 2020Filed 19 MayMar 2021Filed 5 MayMar 2022Filed 24 MayMar 2023Filed 18 MayMar 2024Filed 16 MayMar 2025Filed 12 JunMar 2026Filed 20 Jun
194270103149201248288
Share capital7777771111
Reserves11356396142194237277
03000030160
1317161715162179
15222432137
Total assets336488123166221301503
24352544105174249415
829637861485289
Net debt−21−28−12−9−817154
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 5 MayMar 2022Filed 24 MayMar 2023Filed 18 MayMar 2024Filed 16 MayMar 2025Filed 12 JunMar 2026Filed 20 Jun
114040649149
2155608510860
−20−4−15537−18
Receivables6−107−9−4−30
Inventories0−6−311−2−10
Payables−4330522
Other working capital−219−223380
Tax paid−10−15−20−21−16−11
Interest paid000000
Capital spending3142475116173
Free cash flow72616−10−25−124
−2−30−20−55−112−172
−5−14−13−926115
Dividends paid21012727
Shares bought back000000
Shares issued000000
Net change in cash3−4605−9
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Gujarat Themis Biosyn dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 4 JunMar 2020Filed 19 MayMar 2021Filed 5 MayMar 2022Filed 24 MayMar 2023Filed 18 MayMar 2024Filed 16 MayMar 2025Filed 12 JunMar 2026Filed 20 Jun
–––––––₹8.14₹4.48₹4.28
As stated that year₹2.92₹2.66₹4.41₹16.30₹20.77₹30.03₹39.90₹8.14₹4.48₹4.28
–––––––₹8.14₹4.48₹4.28
Dividend per share––––––––₹0.67₹0.67
–––––––₹27.72₹22.79₹26.41
Dividend payout––––––––15.0%15.6%
Shareholder yield––––0.8%1.7%1.2%0.2%0.1%0.3%
Market cap at the year end (₹ crore)7561571412965929972,8773,0722,472
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.
RatioMar 2017Mar 2018Mar 2019Filed 4 JunMar 2020Filed 19 MayMar 2021Filed 5 MayMar 2022Filed 24 MayMar 2023Filed 18 MayMar 2024Filed 16 MayMar 2025Filed 12 JunMar 2026Filed 20 Jun
Revenue growth–8.7%5.8%107.4%6.4%26.8%29.7%14.0%−11.2%10.0%
Operating profit growth–3.9%17.5%334.2%26.7%43.9%27.9%6.1%−12.6%9.7%
Net profit growth–−8.9%65.7%269.4%27.5%44.5%32.9%2.1%−17.6%−4.3%
Earnings per share growth––––––––−45.0%−4.5%
––34.6%78.0%53.8%50.4%45.9%33.8%21.7%17.4%
–––43.4 pts−24.2 pts−3.5 pts−4.4 pts−12.2 pts−12.1 pts−4.3 pts
From the net margin–––27.0 pts15.5 pts7.5 pts1.2 pts−4.8 pts−2.4 pts−2.8 pts
From asset turnover–––24.8 pts−30.3 pts−5.1 pts−2.8 pts−6.2 pts−10.7 pts−5.4 pts
From borrowing–––−8.5 pts−9.4 pts−5.9 pts−2.9 pts−1.2 pts1.1 pts3.9 pts
Return on capital employed––33.0%67.2%55.2%54.0%48.0%37.3%22.8%14.0%
Cash conversion––––34.9%92.4%68.1%108.5%186.6%104.5%
Interest cover13.812.247.233.039.367.4357.0328.1174.421.2
Debt to equity––0.000.080.000.000.000.000.120.56
Receivable days––52875980445876134
Inventory days––941941442552013375263
Payable days––1,5662408414513199218625
Cash conversion cycle, days––−1,42041119189114−7−67−228
Working capital days––−58408015589504678
Asset turnover––1.251.761.191.091.030.880.580.41
Assets per rupee of net worth––1.771.591.361.221.141.111.161.50
Sales per rupee of plant––2.814.985.336.304.634.813.720.58
Capital spending to depreciation––––1.766.229.2021.1121.6113.35
Plant being built, % of plant in use––6.5%2.1%12.2%69.7%63.9%258.6%454.4%42.2%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
11.6%
Cash from operations against operating profit
64.6%
Measure10 years5 years3 years
Revenue growth, yearly rate–12.9%3.6%
Profit growth, yearly rate–9.1%−7.0%
Return on equity, average–33.8%24.3%
Return on capital employed, average–35.2%24.7%
Operating margin, average37.1%47.6%45.9%
Net margin, average27.1%34.4%31.8%
Asset turnover, average–0.800.62
Cash conversion cycle, days, average–0−101
Interest cover, average109.4189.6174.6
Debt to equity, average–0.140.23

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations28420449
Cash from investing−390−339−172
Cash from financing105132115
Capital spending401363173
Dividends paid38167
Shares bought back000
Shares issued for cash000
Borrowings raised160160130
Borrowings repaid300

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––463445
Altman Z-scorePublished threshold 1.81––4.827.8313.9222.7738.7890.8337.278.43
Beneish M-scorePublished threshold −1.78––––−1.77−1.20−1.47−1.92−3.43−2.40
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––28.7531.4526.9225.8926.6342.29
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.690.901.171.32
Receivables growth less revenue growthOur threshold 0 percentage points–––141.52−33.6543.89−58.4236.9426.7985.04
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––920.81−35.2683.84−33.54−115.6984.87218.30
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––0.2016.09−2.71−6.924.45−3.921.94
Assets under construction, years of additionsOur threshold 2 years of additions–––0.091.263.661.2413.8117.270.47
Effective tax ratePublished threshold 17.16 per cent9.6620.0721.8024.2626.1826.1025.1725.4325.5824.82
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––1.51−1.20−0.900.437.67
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
15 Jul 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - ST-BG/LCCARE A3+ (Rating Watch with Negative Implications)Review, Re-affirm5
15 Jul 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Term LoanCARE BBB (Rating Watch with Negative Implications)Review, Re-affirm75
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.